Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
41527
CAS Number:
128345-57-3
( S )-(-)-3-Aminopirrolidina
Purity:
≥ 99% (pureza quiral)
Synonym(s):
(3 S )-(-)-3-Aminopirrolidina
Hazmat
Documents
$180.27 /1G
Tamaño
Request Bulk Quote
Información del producto
Número CAS
128345-57-3
Fórmula molecular
C4H10N2
Peso molecular
0
Número MDL
MFCD00143193
Densidad
0,967 g/mL a 25 °C (Lit.)
Punto de ebullición
164 - 165 °C (Literatura)
Índice de refracción
n20D 1.48 (Literatura)
Rotación óptica
[ á]20/D = 20 ° limpio
Condiciones
Tienda en RT
Información general
Número CAS
128345-57-3
Fórmula molecular
C4H10N2
Peso molecular
0
Número MDL
MFCD00143193
Densidad
0,967 g/mL a 25 °C (Lit.)
Punto de ebullición
164 - 165 °C (Literatura)
Índice de refracción
n20D 1.48 (Literatura)
Rotación óptica
[ á]20/D = 20 ° limpio
Condiciones
Tienda en RT
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

(S)-(-)-3-Aminopyrrolidine is widely utilized in research focused on

  • Pharmaceutical Development: This compound serves as a key intermediate in the synthesis of various pharmaceuticals, particularly in the development of drugs targeting neurological disorders.
  • Chiral Catalysis: Its chiral nature makes it an excellent candidate for asymmetric synthesis, enhancing the efficiency of producing enantiomerically pure compounds in the pharmaceutical industry.
  • Neurotransmitter Research: Researchers use this compound to study its effects on neurotransmitter systems, which can lead to advancements in treatments for conditions like depression and anxiety.
  • Material Science: It is applied in the development of new materials, particularly in creating polymers with enhanced properties for use in various industrial applications.
  • Biochemical Assays: The compound is utilized in biochemical assays to investigate enzyme interactions and mechanisms, providing insights into metabolic pathways.

Citas